Company Theralase Technologies Inc.

Equities

TLT

CA88337V1004

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Theralase Technologies Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Laser Equipment

Market Closed - Toronto S.E. Other stock markets 12:47:19 2024-04-26 pm EDT			5-day change	1st Jan Change
0.16 ^CAD	-3.03%		0.00%	-8.57%

Apr. 24	Theralase Technologies Inc. announced that it has received CAD 0.7502 million in funding	CI
Apr. 05	Theralase Technologies Inc. Receives Canadian Cancer Vaccine Patent	CI

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Companyâs medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

Number of employees: 20

CAD in Million	2022	Weight	2023	Weight	Delta
Device 100.0 %	1	100.0 %	1	100.0 %	-6.00%

CAD in Million	2022	Weight	2023	Weight	Delta
Canada 78.5 %	1	88.5 %	1	78.5 %	-16.63%
United States 21.3 %	0	9.8 %	0	21.3 %	+103.85%
International 0.2 %	0	1.6 %	0	0.2 %	-90.99%

Managers	Title	Age	Since
Roger Dumoulin-White FOU	Founder	-	89-08-21
Kristina Hachey DFI	Director of Finance/CFO	-	19-06-26
Arkady Mandel CTO	Chief Tech/Sci/R&D Officer	-	17-12-31
Vera Madzarevic PRN	Corporate Officer/Principal	-	21-10-24
Maria Delos Reyes AUD	Comptroller/Controller/Auditor	-	-
Kyle Shantz SAM	Sales & Marketing	-	14-07-31

Members of the board	Title	Age	Since
Roger Dumoulin-White FOU	Founder	-	89-08-21
Kristina Hachey DFI	Director of Finance/CFO	-	19-06-26
Randy Bruder BRD	Director/Board Member	-	07-12-31
Arkady Mandel CTO	Chief Tech/Sci/R&D Officer	-	17-12-31
Matthew Perraton CHM	Chairman	-	13-01-31
Guy Anderson BRD	Director/Board Member	-	12-12-31
Kaouthar Lbiati BRD	Director/Board Member	45	23-06-05

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	228,460,858	204,979,887 ( 89.72 %)	0	89.72 %

Name	Equities	%	Valuation
Roger Dumoulin-White 4.993 %	11,049,331	4.993 %	1 M $
Kristina Hachey 1.371 %	3,034,045	1.371 %	361 051 $
Randy Bruder 0.8441 %	1,868,078	0.8441 %	222 301 $
Guy Anderson 0.2948 %	652,348	0.2948 %	77 629 $
Arkady Mandel 0.1351 %	298,889	0.1351 %	35 568 $
Matthew Perraton 0.0230 %	50,900	0.0230 %	6 057 $
Strategic Investment Solutions, Inc. (Illinois) 0.002259 %	5,000	0.002259 %	595 $
Kaouthar Lbiati 0.000000 %	0	0.000000 %	- $

Theralase Technologies, Inc.

41 Hollinger Road

M4B 3G4, Toronto

+416-699-5273

http://www.theralase.com

address Theralase Technologies Inc.(TLT)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.16 CAD

Average target price

0.8 CAD

Spread / Average Target

+400.00%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Laser Equipment

	1st Jan change	Capi.
THERALASE TECHNOLOGIES INC.	-8.57%	27.97M
CLINICAL LASERTHERMIA SYSTEMS AB	-37.75%	12.3M
EL.EN. S.P.A.	+19.38%	994M
SISRAM MEDICAL LTD	-32.70%	212M
LASEROPTEK CO., LTD.	-35.85%	74.33M

Laser Equipment